0001093557-19-000193.txt : 20190911 0001093557-19-000193.hdr.sgml : 20190911 20190911212830 ACCESSION NUMBER: 0001093557-19-000193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190909 FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOUBLEDAY RICHARD CENTRAL INDEX KEY: 0001466545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 191089403 MAIL ADDRESS: STREET 1: C/O DEXCOM, INC. STREET 2: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-09-09 0 0001093557 DEXCOM INC DXCM 0001466545 DOUBLEDAY RICHARD 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP Chief Commercial Officer Common Stock 2019-09-09 4 S 0 318 145.3793 D 72346 D Common Stock 2019-09-09 4 S 0 5525 150.1111 D 66821 D Common Stock 2016 I by Trust Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. This transaction was executed in multiple trades at prices ranging from $145.34 to $145.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 40,201 unvested restricted stock units, 16,365 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. By: Jereme Sylvain For: Richard B Doubleday 2019-09-11